However, considering PTHC and SMO expression, we observed significant time survival differences with ccRCC patients with a high expression of PTCH and a low expression of SMO (p = 0.0005 and p = 0.029, respectively). Here, SMO is linked to nonpapillary renal cell carcinoma.